Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Ganoderenic acid D is a triterpenoid originally isolated from G. lucidum and has diverse biological activities.1,2,3,4 It inhibits angiotensin-converting enzyme (ACE; IC50 = 734 µM).2 Ganoderenic acid D is cytotoxic to HepG2 liver, HeLa cervical, and Caco-2 colon cancer cells (IC50s = 0.14, 0.18, and 0.26 mg/ml, respectively).3 It inhibits LPS-induced nitric oxide (NO) production in BV-2 microglia (IC50 = 13.77 µM).4
WARNING This product is not for human or veterinary use.
1. Structures of new terpenoid constituents of Ganoderma lucidum (Fr.) KARST (Polyporaceae). Chem. Pharm. Bull. 33(11), 4829-4835 (1985).
2. Structure–activity relationship and inhibition pattern of reishi-
3. Extraction optimisation and isolation of triterpenoids from Ganoderma lucidum and their effect on human carcinoma cell growth. Nat. Prod. Res. 28(24), 2264-2272 (2014).
4. Lanostane triterpenoids from Ganoderma curtisii and their NO production inhibitory activities of LPS-